These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6284782)

  • 21. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Consequences of hyperglycemia on glucose and nitrogen metabolism in liver cirrhosis. A study using a hyperglycemic clamp].
    Vetter D; Fratte S; Winiszewski P; Reville M; Hirsch E; Roze F; Blickle JF; Pinget M; Doffoel M; Bockel R
    Gastroenterol Clin Biol; 1990; 14(5):483-91. PubMed ID: 2194890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased insulin binding to monocytes from normal pregnant women.
    Beck-Nielsen H; Kühl C; Pedersen O; Bjerre-Christensen C; Nielsen TT; Klebe JG
    J Clin Endocrinol Metab; 1979 Dec; 49(6):810-4. PubMed ID: 511971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin receptor on monocytes from patients with acromegaly and fasting hyperglycemia.
    Muggeo M; Saviolakis GA; Businaro V; Valerio A; Moghetti P; Crepaldi G
    J Clin Endocrinol Metab; 1983 Apr; 56(4):733-8. PubMed ID: 6339536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ].
    Esteva Díaz F; Ducóns García J; Ceña Lázaro G; Márquez Galván M; Juste Rullo G; Barrao Comps F
    Rev Clin Esp; 1986 Nov; 179(7):347-51. PubMed ID: 3025944
    [No Abstract]   [Full Text] [Related]  

  • 28. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of glucagon on blood gastrin levels in hepatic cirrhosis: correlation with blood levels of cyclic AMP].
    Francavilla A; Sansonno D; Ierardi E; Amoruso A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2588-93. PubMed ID: 6258616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation.
    Merli M; Leonetti F; Riggio O; Valeriano V; Ribaudo MC; Strati F; Tisone G; Casciani CU; Capocaccia L
    Hepatology; 1999 Sep; 30(3):649-54. PubMed ID: 10462370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucoregulatory hormones in hepatic cirrhosis.
    Saini JS; Pruthi HS; Naqvi S; Karnani I; Shetty KJ
    J Assoc Physicians India; 1992 Jul; 40(7):448-51. PubMed ID: 1484025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
    Keller U; Sonnenberg GE; Burckhardt D; Perruchoud A
    J Clin Endocrinol Metab; 1982 May; 54(5):961-8. PubMed ID: 6120952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma insulin and C-peptide levels in cirrhotic and uremic patients.
    Kawai K; Hayakawa H; Yoshida K; Shimizu M; Noto Y
    Diabete Metab; 1977 Mar; 3(1):7-10. PubMed ID: 323089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The insulin receptor in myotonic dystrophy.
    Kobayashi M; Meek JC; Streib E
    J Clin Endocrinol Metab; 1977 Oct; 45(4):821-4. PubMed ID: 914985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.
    Bar RS; Levis WR; Rechler MM; Harrison LC; Siebert C; Podskalny J; Roth J; Muggeo M
    N Engl J Med; 1978 May; 298(21):1164-71. PubMed ID: 651946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
    Marchesini G; Forlani G; Angiolini A; Zoli M; Scolari MP; Bianchi FB; Pisi E
    Diabete Metab; 1979 Jun; 5(2):135-9. PubMed ID: 478083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin receptors in acute infection: a study of factors conferring insulin resistance.
    Drobny EC; Abramson EC; Baumann G
    J Clin Endocrinol Metab; 1984 Apr; 58(4):710-6. PubMed ID: 6365946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
    Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.
    Pun KK; Ho PW; Yeung RT
    J Endocrinol Invest; 1988 May; 11(5):337-43. PubMed ID: 2846676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.
    Francavilla A; Jones AF; Starzl TE
    Gastroenterology; 1978 Dec; 75(6):1026-32. PubMed ID: 213345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.